References
- Fischer WA 2nd, Gong M, Bhagwanjee S, et al. Global burden of influenza as a cause of cardiopulmonary morbidity and mortality. Glob Heart. 2014;9(3):325–336.
- Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012 Nov 23;87(47):461–476.
- Avritscher EB, Cooksley CD, Geraci JM, et al. Cost‐effectiveness of influenza vaccination in working‐age cancer patients. Cancer. 2007;109(11):2357–2364.
- Hajjar L, Mauad T, Galas FG, et al. Severe novel influenza A (H1N1) infection in cancer patients. Ann Oncol. 2010;21(12):2333–2341.
- Souza TML, Salluh JI, Bozza FA, et al. H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis. PLoS One. 2010;5(11):e14158.
- Cooksley CD, Avritscher EB, Bekele BN, et al. Epidemiology and outcomes of serious influenza‐related infections in the cancer population. Cancer. 2005;104(3):618–628.
- von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
- SEER database. [cited 2019 Oct 29]. Available from: https://seer.cancer.gov/registries/terms.html
- Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. Vol. 360. John Wiley & Sons; 2011.
- Penn I, Starzl TE. Immunosuppression and cancer. Transplant Proc. 1973;5(1):943–947.
- Han L, Ran J, Mak Y-W, et al. Smoking and influenza-associated morbidity and mortality: a systematic review and meta-analysis. Epidemiology. 2019;30(3):405–417.
- Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337.
- Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 20;395(10241):1907–1918.
- Quandelacy TM, Viboud C, Charu V, et al. Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997–2007. Am J Epidemiol. 2014;179(2):156–167.
- Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 21(7):904–913.
- Abdel-Rahman O. Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study. Int J Clin Oncol. 2020 Jan 18;25(5):861–866.
- Abdel-Rahman O. Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database. Int J Clin Oncol. 2019 Dec;24(12):1582–1587.
- Abdel-Rahman O. Impact of NCI socioeconomic index on the outcomes of nonmetastatic breast cancer patients: analysis of SEER census tract-level socioeconomic database. Clin Breast Cancer. 2019 Dec;19(6):e717–e722.
- Bitterman R, Eliakim-Raz N, Vinograd I, et al. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev. 2018 Feb 1;2:Cd008983.
- Toleman MS, Herbert K, McCarthy N, et al. Vaccination of chemotherapy patients–effect of guideline implementation. Support Care Cancer. 2016 May;24(5):2317–2321.
- Vollaard A, Schreuder I, Slok-Raijmakers L, et al. Influenza vaccination in adult patients with solid tumours treated with chemotherapy. Eur J Cancer. 2017 May;76:134–143.
- Loulergue P, Mir O, Alexandre J, et al. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol. 2008;19(9):1658.
- Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol. 2010;28(14):2481–2490.
- Bersanelli M, Buti S, De Giorgi U, et al. State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: when common sense is not enough. Crit Rev Oncol Hematol. 2019 July;139:87–90.